Friday, May 6th, 2016

The report “Peritoneal Cancer – Pipeline Review, H1 2016” provides comprehensive information on the therapeutics under development for Peritoneal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Peritoneal Cancer and features dormant and discontinued projects.

Complete Report Details Available at .

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Inquire more about this report at .

Peritoneal Cancer – Companies Involved in Therapeutics Development:

AbbVie Inc.
Acetylon Pharmaceuticals, Inc.
Adaptimmune Therapeutics Plc
Aduro BioTech, Inc.
Advanced Accelerator Applications SA
Advenchen Laboratories, LLC
Amgen Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
AstraZeneca Plc
Atara Biotherapeutics, Inc.
AVEO Pharmaceuticals, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Caladrius Biosciences, Inc.
Celldex Therapeutics, Inc.
Celsion Corporation
CerRx, Inc.
Cerulean Pharma, Inc.
Clovis Oncology, Inc.
Corcept Therapeutics Incorporated
Critical Outcome Technologies Inc.
CritiTech, Inc.
CTI BioPharma Corp.
Dr. Reddy’s Laboratories Limited
EirGenix Inc.
Eli Lilly and Company
Epirus Biopharmaceuticals, Inc.
Exelixis, Inc.
F. Hoffmann-La Roche Ltd.
Galena Biopharma, Inc.
Ganymed Pharmaceuticals AG
Genelux Corporation
Genentech, Inc.
Genor BioPharma Co., Ltd.
Glycotope GmbH
Gradalis Inc.
Hemispherx Biopharma, Inc.
ImmunoGen, Inc.
Immunovaccine, Inc.
Incyte Corporation
Innate Pharma S.A.
Johnson & Johnson
Juno Therapeutics Inc.
Kyowa Hakko Kirin Co., Ltd.
Lee’s Pharmaceutical Holdings Limited
Mabion SA
MabVax Therapeutics Holdings, Inc.
MedImmune, LLC
Medivation, Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
MolMed S.p.A.
Mycenax Biotech Inc.
Novartis AG
Oasmia Pharmaceutical AB
OBI Pharma, Inc.
Oncobiologics, Inc.
Oncolix, Inc.
Oncolytics Biotech Inc.
OncoMed Pharmaceuticals, Inc.
Ono Pharmaceutical Co., Ltd.
Oxford BioMedica Plc
Pharma Mar, S.A.
Pharmacyclics, Inc.
PsiOxus Therapeutics Limited
Quest PharmaTech Inc.
Sanofi Pasteur SA
Shenzen SiBiono GeneTech Co., Ltd.
Sotio a.s.
Synta Pharmaceuticals Corp.
TapImmune Inc.
Tesaro, Inc.
TetraLogic Pharmaceuticals
Tyrogenex, Inc.
Vascular Biogenics Ltd.
VentiRx Pharmaceuticals, Inc.


– The report provides a snapshot of the global therapeutic landscape of Peritoneal Cancer

– The report reviews pipeline therapeutics for Peritoneal Cancer by companies and universities/research institutes based on information derived from company and industry-specific sources

– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

– The report reviews key players involved Peritoneal Cancer therapeutics and enlists all their major and minor projects

– The report assesses Peritoneal Cancer therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

– The report summarizes all the dormant and discontinued pipeline projects

– The report reviews latest news related to pipeline therapeutics for Peritoneal Cancer

Reasons to buy

– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of therapeutics under development for Peritoneal Cancer

– Identify potential new clients or partners in the target demographic

– Develop strategic initiatives by understanding the focus areas of leading companies

– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

– Devise corrective measures for pipeline projects by understanding Peritoneal Cancer pipeline depth and focus of Indication therapeutics

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Get a sample copy at .

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Peritoneal Cancer Therapeutics, Peritoneal Cancer Therapeutics Market, Peritoneal Cancer Therapeutics Market Trends, Peritoneal Cancer Therapeutics Industry Trends, Peritoneal Cancer Therapeutics Market Share, Peritoneal Cancer Therapeutics Market Growth




More Formats

View QR Code